...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: IND filing for Renal Trial
4
Mar 20, 2017 04:41PM
4
Mar 20, 2017 05:49PM

Tada,

Thanks for the clarification. However, I still don't understand why you think that the Renal IND/trial approval would be such a catalyst for the share price. Based on the various trials to date, we know that RVX-208/apabetalone is at least safe enough for no red flags to arise other than the minor and transient liver transaminase elevation is a subset of patients. So the Renal IND/trial approval shouldn't come as too much of a surprise. It's not so much a matter of if the IND/trial will be approved but when. And this would just be the start of the trial, not the results of the trial.

Could you please elaborate on why you think "this could literally be the beginning of the launch into the stratosphere for our share price"

Thanks,

BDAZ

6
Mar 20, 2017 11:11PM
3
Mar 23, 2017 02:33PM
Share
New Message
Please login to post a reply